185 related articles for article (PubMed ID: 7751637)
41. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
Godet Y; Moreau-Aubry A; Mompelat D; Vignard V; Khammari A; Dreno B; Lang F; Jotereau F; Labarriere N
Cancer Immunol Immunother; 2010 Mar; 59(3):431-9. PubMed ID: 19730858
[TBL] [Abstract][Full Text] [Related]
42. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.
Lu YC; Yao X; Crystal JS; Li YF; El-Gamil M; Gross C; Davis L; Dudley ME; Yang JC; Samuels Y; Rosenberg SA; Robbins PF
Clin Cancer Res; 2014 Jul; 20(13):3401-10. PubMed ID: 24987109
[TBL] [Abstract][Full Text] [Related]
43. Cloning and in vitro expression of a melanoma-associated antigen immunogenic in patients with melanoma.
Hayashibe K; Mishima Y; Ferrone S
J Immunol; 1991 Aug; 147(3):1098-104. PubMed ID: 1861072
[TBL] [Abstract][Full Text] [Related]
44. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
[TBL] [Abstract][Full Text] [Related]
45. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
Kawakami Y; Eliyahu S; Delgado CH; Robbins PF; Rivoltini L; Topalian SL; Miki T; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3515-9. PubMed ID: 8170938
[TBL] [Abstract][Full Text] [Related]
46. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
[TBL] [Abstract][Full Text] [Related]
47. Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1.
Ramirez-Montagut T; Andrews DM; Ihara A; Pervaiz S; Pandolfi F; Van Den Elsen PJ; Waitkus R; Boyle LA; Hishii M; Kurnick JT
Clin Exp Immunol; 2000 Jan; 119(1):11-8. PubMed ID: 10606959
[TBL] [Abstract][Full Text] [Related]
48. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
Rosenberg SA
Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
[TBL] [Abstract][Full Text] [Related]
49. A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
Larrieu P; Renaud V; Godet Y; Jotereau F; Fonteneau JF
Cancer Immunol Immunother; 2008 May; 57(5):745-52. PubMed ID: 18097665
[TBL] [Abstract][Full Text] [Related]
50. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.
Wang RF; Wang X; Rosenberg SA
J Exp Med; 1999 May; 189(10):1659-68. PubMed ID: 10330445
[TBL] [Abstract][Full Text] [Related]
51. Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.
Maccalli C; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
Cancer Res; 2003 Oct; 63(20):6735-43. PubMed ID: 14583468
[TBL] [Abstract][Full Text] [Related]
52. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.
Pieper R; Christian RE; Gonzales MI; Nishimura MI; Gupta G; Settlage RE; Shabanowitz J; Rosenberg SA; Hunt DF; Topalian SL
J Exp Med; 1999 Mar; 189(5):757-66. PubMed ID: 10049939
[TBL] [Abstract][Full Text] [Related]
53. Dissection of T-cell antigen specificity in human melanoma.
Andersen RS; Thrue CA; Junker N; Lyngaa R; Donia M; Ellebæk E; Svane IM; Schumacher TN; Thor Straten P; Hadrup SR
Cancer Res; 2012 Apr; 72(7):1642-50. PubMed ID: 22311675
[TBL] [Abstract][Full Text] [Related]
54. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.
Wang RF; Parkhurst MR; Kawakami Y; Robbins PF; Rosenberg SA
J Exp Med; 1996 Mar; 183(3):1131-40. PubMed ID: 8642255
[TBL] [Abstract][Full Text] [Related]
55. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.
Hom SS; Schwartzentruber DJ; Rosenberg SA; Topalian SL
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):18-30. PubMed ID: 8435428
[TBL] [Abstract][Full Text] [Related]
56. Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.
Khong HT; Wang QJ; Rosenberg SA
J Immunother; 2004; 27(3):184-90. PubMed ID: 15076135
[TBL] [Abstract][Full Text] [Related]
57. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.
Wang RF; Appella E; Kawakami Y; Kang X; Rosenberg SA
J Exp Med; 1996 Dec; 184(6):2207-16. PubMed ID: 8976176
[TBL] [Abstract][Full Text] [Related]
58. Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.
Junker N; Kvistborg P; Køllgaard T; Straten Pt; Andersen MH; Svane IM
Cell Immunol; 2012; 273(1):1-9. PubMed ID: 22230732
[TBL] [Abstract][Full Text] [Related]
59. T-cell recognition of human melanoma antigens.
Kawakami Y; Nishimura MI; Restifo NP; Topalian SL; O'Neil BH; Shilyansky J; Yannelli JR; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):88-93. PubMed ID: 8280705
[TBL] [Abstract][Full Text] [Related]
60. Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.
Lu YC; Yao X; Li YF; El-Gamil M; Dudley ME; Yang JC; Almeida JR; Douek DC; Samuels Y; Rosenberg SA; Robbins PF
J Immunol; 2013 Jun; 190(12):6034-42. PubMed ID: 23690473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
